Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The European Gazette.
Press releases published on April 17, 2025

Addex Regains Rights to Phase 2 mGlu2 PAM Asset ADX71149
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, April 17, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for …

WISeKey, SEALSQ, OISTE Foundation, and the United Nations Alliance of Civilizations Unite to Launch HUMAN-AI-T, a Global Initiative to Embed Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered Artificial Intell
WISeKey, SEALSQ, OISTE Foundation, and the United Nations Alliance of Civilizations Unite to Launch HUMAN-AI-T, a Global Initiative to Embed Humanity into Artificial Intelligence UNAOC AI for #OneHumanity: Human-Centered Artificial Intelligence Geneva, …

WISeKey, SEALSQ, la Fundación OISTE y la Alianza de Civilizaciones de las Naciones Unidas se unen para lanzar HUMAN-AI-T, una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC IA para #UnaHumanidad: Inteligen
WISeKey, SEALSQ, la Fundación OISTE y la Alianza de Civilizaciones de las Naciones Unidas se unen para lanzar HUMAN-AI-T, una iniciativa global para integrar la humanidad en la inteligencia artificial UNAOC IA para #UnaHumanidad: Inteligencia Artificial …

Mesoblast Extends Payer Coverage For Ryoncil® to Over 100 Million US Lives
NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that it has continued to expand coverage for Ryoncil® (remestemcel-L), the first …